Clinical Trial Detail

NCT ID NCT03063944
Title STAT Inhibitor OPB-111077 and Decitabine in Treating Patients With Acute Myeloid Leukemia That Is Refractory or Newly Diagnosed and Ineligible for Intensive Chemotherapy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Cancer Center at Thomas Jefferson University
Indications

acute myeloid leukemia

Therapies

Decitabine + OPB-111077

Age Groups: adult senior

No variant requirements are available.